Controlled trials of inositol in psychiatry

By Levine J.  

European Neuropsychopharmacology, Vol. 7, Iss. 2, 1997-05 ,pp. : 147-155

Elsevier

Access to resources Recommend Favorite

Risk Management of Medicines and Compensation for Harm

By Edwards I. Ralph  

Drug Safety, Vol. 32, Iss. 2, 2009-01 ,pp. : 87-90

Adis International

Access to resources Recommend Favorite

Increased Risk of Somnolence with the New Dopamine Agonists in Patients with Parkinson's Disease: A Meta-Analysis of Randomised Controlled Trials

By Etminan M.  

Drug Safety, Vol. 24, Iss. 11, 2001-01 ,pp. : 863-868

Adis International

Access to resources Recommend Favorite

Alternatives to placebo-controlled trials in psychiatry

By Montgomery S.A.  

European Neuropsychopharmacology, Vol. 9, Iss. 3, 1999-03 ,pp. : 265-269

Elsevier

Access to resources Recommend Favorite

Meta-Analysis of Placebo-Controlled Trials of Aprotinin Assessing the Relative Risk of Reoperations in Patients Undergoing Coronary Artery Bypass Graft Surgery

By Kübler J.   Hecker-Barth G.  

Clinical Drug Investigation, Vol. 19, Iss. 3, 2000-03 ,pp. : 167-171

Adis International

Access to resources Recommend Favorite